Weeks after TIGIT fail, iTeos decides to wind downnews2025-05-28T14:42:16+00:00May 28th, 2025|Endpoints News|
Updated: MD Anderson-allied investment firm targets $250M for second cancer biotech fundnews2025-05-28T10:58:37+00:00May 28th, 2025|Endpoints News|
Biogen taps City Therapeutics in RNAi deal worth up to $1Bnews2025-05-27T13:19:48+00:00May 27th, 2025|Endpoints News|
Investors pump $130M into protein degrader startup GlycoEranews2025-05-27T11:00:13+00:00May 27th, 2025|Endpoints News|
TCG’s R&D venture team makes a T cell engager deal with Shanghai biotechnews2025-05-27T10:00:57+00:00May 27th, 2025|Endpoints News|
Biotech downturn exposes startups to big lease liabilitiesnews2025-05-21T15:00:43+00:00May 21st, 2025|Endpoints News|
Altos Labs buys anti-aging startup Dorian Therapeuticsnews2025-05-21T08:26:22+00:00May 21st, 2025|Endpoints News|
Reproductive health biotech ReproNovo closes $65M Series Anews2025-05-21T08:18:02+00:00May 21st, 2025|Endpoints News|
UK biotech Juvenescence targets $150M+ for ‘healthy lifespan’ drug candidatesnews2025-05-21T06:00:32+00:00May 21st, 2025|Endpoints News|
Weight loss startup Calibrate replaces CEO in leadership shakeup news2025-05-20T13:39:00+00:00May 20th, 2025|Endpoints News|
